Afya (NASDAQ:AFYA – Get Free Report) is projected to issue its Q3 2026 results after the market closes on Thursday, November 12th. Analysts expect Afya to post earnings of $0.3791 per share and revenue of $190.41 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 12, 2026 at 5:00 PM ET.
Afya (NASDAQ:AFYA – Get Free Report) last announced its quarterly earnings data on Friday, August 14th. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.03. Afya had a net margin of 20.55% and a return on equity of 17.58%. The company had revenue of $187.80 million for the quarter, compared to analysts’ expectations of $189.62 million. On average, analysts expect Afya to post $1.72 EPS for the current fiscal year and $1.83 EPS for the next fiscal year.
Afya Stock Down 0.5%
NASDAQ AFYA opened at $10.50 on Thursday. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.20 and a quick ratio of 2.20. The company’s 50 day simple moving average is $13.40 and its 200 day simple moving average is $14.14. Afya has a 12 month low of $9.66 and a 12 month high of $16.16. The company has a market capitalization of $984.06 million, a P/E ratio of 5.99, a PEG ratio of 1.65 and a beta of 0.43.
Insider Buying and Selling
In other Afya news, insider Santos Welder Ferreira sold 4,161 shares of the company’s stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $13.30, for a total transaction of $55,341.30. Following the completion of the sale, the insider directly owned 35,000 shares of the company’s stock, valued at approximately $465,500. This represents a 10.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.80% of the company’s stock.
Analysts Set New Price Targets
AFYA has been the subject of a number of research reports. Weiss Ratings cut shares of Afya from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, October 29th. Zacks Research raised Afya from a “strong sell” rating to a “hold” rating in a report on Monday, October 5th. Bank of America raised Afya from a “neutral” rating to a “buy” rating and set a $16.00 price target on the stock in a report on Thursday, October 29th. Wall Street Zen downgraded Afya from a “buy” rating to a “hold” rating in a research report on Saturday, October 31st. Finally, Citigroup raised Afya from a “neutral” rating to a “buy” rating and reduced their price objective for the stock from $16.00 to $12.00 in a research note on Tuesday. Four investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Afya presently has a consensus rating of “Hold” and an average price target of $15.70.
Read Our Latest Report on Afya
About Afya
Afya Limited is a medical education and digital health company focused on Brazil. Through its educational platform, the company provides undergraduate medical education, medical residency preparation, specialization and continuing medical education programs, and other learning resources for students and physicians.
Afya also offers digital products and services intended to support healthcare professionals throughout their careers. These include clinical content, study tools, telemedicine and practice-management solutions, and subscription-based applications designed to assist physicians with education, clinical decision-making, and patient care.
The company has expanded through the development and acquisition of medical schools, education businesses, and health technology platforms serving different stages of the medical professional lifecycle.
Featured Stories
- Five stocks we like better than Afya
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
